Cargando…
12621 Targeted Chemical-Genetic Screen Platform for Identifying Drug Modes-of-Action
ABSTRACT IMPACT: The key to advancing precision medicine is to deepen our understanding of drug modes-of-action (MOA). This project aims to develop a novel method for predicting MOA of potential drug compounds, providing an experimental and computational platform for more efficient drug discovery. O...
Autores principales: | Lin, Kevin, Billmann, Maximilian, Ward, Henry, Chang, Ya-Chu, Bielinsky, Anja-Katrin, Myers, Chad L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827809/ http://dx.doi.org/10.1017/cts.2021.661 |
Ejemplares similares
-
RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication
por: Chang, Ya-Chu, et al.
Publicado: (2023) -
372 HMGB1 Localization as a Driver of Carcinogenesis in RDEB-Associated Squamous Cell Carcinoma
por: Bui, Kacey Guenther, et al.
Publicado: (2023) -
Scalable CRISPR-Cas9 chemical genetic screens in non-transformed human cells
por: Lin, Kevin, et al.
Publicado: (2022) -
4485 Silicone Implant Shells Increase the Rate of Proliferation of Patient-Derived BIA-ALCL Cells but Not Primary T Cells in an Engineered Biomimetic Breast Platform
por: Premaratne, Ishani, et al.
Publicado: (2020) -
4106 Personalizing Care For Colorectal Cancer: Identifying Novel Opportunities
por: Rivers, Zachary, et al.
Publicado: (2020)